Global Western Blotting Market Report 2023: Increasing Adoption of Organic Growth Strategies Drives Growth
May 29, 2023 10:03 ET
|
Research and Markets
Dublin, May 29, 2023 (GLOBE NEWSWIRE) -- The "Western Blotting Market, By Product Type Electrophoresis Blotting Systems, Reagents & Kits, Fluorescent Reagents, Antibodies, Buffer Kits, Transfer...
Global CD137 Antibodies Clinical Trials Research Report 2023: Increasing Investment in the Cancer Therapeutics Domain & Involvement of Prominent Companies Driving the CD137 Market
May 22, 2023 04:08 ET
|
Research and Markets
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global CD137 Antibodies Clinical Trials & Market Trends Insight 2023" report has been added to ResearchAndMarkets.com's offering. The therapeutic...
Global Biopharma Buffer Market Report 2023: Increasing Demand for Aqueous Solutions for Cleaning and Disinfecting Downstream Processing Equipment Drives Growth
May 18, 2023 09:58 ET
|
Research and Markets
Dublin, May 18, 2023 (GLOBE NEWSWIRE) -- The "Biopharma Buffer Market, By Type, By Application, By End User, By Buffer Component, By Buffer Preparation, By Material Form, By Region - Size, Share,...
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023: Trends, Key Players, Documents and Figures
May 11, 2023 05:18 ET
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.com's offering.The Global...
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 10, 2023 16:00 ET
|
Dyadic International, Inc.
New research collaboration with a Top 5 pharmaceutical company to develop C1 expressed vaccine antigen for human healthExpanded licensing agreement with Rubic One Health (“Rubic”) to develop,...
Global Cancer Monoclonal Antibodies Market Report 2023: Sector is Expected to Reach $106.8 Billion by 2031
May 08, 2023 07:28 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market by Antibody Type, Application, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has...
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
April 26, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Biosimilars Market Size to Cross USD 85 Bn Valuation by 2031 | Transparency Market Research
April 18, 2023 14:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 19, 2023 (GLOBE NEWSWIRE) -- The global biosimilars market stood at USD 20.4 Bn in 2021 and is expected to surpass USD 85 Bn by 2031, expanding at a CAGR...
Antibodies Contract Manufacturing Market Set to Reach US$17.5 Billion by 2033, Says Persistence Market Research
April 17, 2023 11:35 ET
|
Persistence Market Research
New York, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Antibodies Contract Manufacturing Market generated US$ 4.8 billion in revenue in 2022, and it is anticipated that this market will grow at a...
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
April 12, 2023 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...